BLUTTEST AUF EGFR-MUTATIONEN

European patent · EP2964781 · In force

Register entry

Publication number
EP2964781
Application number
EP14708273
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 7, 2014
Published
Jan 13, 2016
Granted
Jan 10, 2018
Protection ends at the latest
Mar 6, 2034
Next annual fee due
Mar 31, 2027
IPC classes
C12Q 1/68 (2018.01)
Priority
US 201361774946 P 08.03.2013
US 201361886619 P 03.10.2013
PCT application
PCT/EP2014/054409 07.03.2014
PCT publication
WO2014/135669 12.09.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  4. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  5. Jan 10, 2018

    Granted

    Published in Swissreg on 10.01.2018

Parties

Holder

F. Hoffmann-La Roche AG

Grenzacherstrasse 124, 4070 Basel

Inventor

KLUGHAMMER, Barbara

79618 Rheinfelden, DE

MELDGAARD, Peter

DK-8230 Aabyhoj, DK

SORENSEN, Boe

DK-8330 Beder, DK

TSAI, Julie

Newark California 94560, US

WEN, Wei

Santa Clara California 95051, US

WU, Lin

Moraga California 94556, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.